GSK3B and hepatocellular carcinoma: To further confirm these results in HCC cells, we stabilized β-catenin protein by treating HepG2 and HuH7 cells with lithium chloride (LiCl), an inhibitor of GSK3β, which is responsible for β-catenin degradation.